Not yet recruiting
RE and Probiotics in MAFLD/NAFLD
NCT06563921
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
- Locations
-
Not specified
Clinical trial condition
NASH
Explore clinical trials studying NASH. Study availability and eligibility vary by location and protocol.
44 public trials
9 recruiting studies
NASH trial results
Not yet recruiting
Precise Evaluation Criteria for Histological Regression of NASH Fibrosis
NCT06364462
- Conditions
- Digestive System Diseases, Fibrosis, Liver Cirrhosis, +5 more
- Locations
-
Not specified
Not yet recruiting
Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)
NCT05857319
- Conditions
- Apnea, Body Weight, Cardiovascular Diseases, +29 more
- Locations
-
Not specified
Not yet recruiting
THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)
NCT04925362
- Conditions
- Cirrhosis, Digestive System Diseases, Fatty Liver, +8 more
- Locations
-
Not specified
Active, not recruiting
Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease
NCT06888310
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
- Locations
-
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Medicina Interna e Trapianto di Fegato Roma, Italy
Active, not recruiting
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
NCT05500222
- Conditions
- Cirrhosis, Liver, Digestive System Diseases, Fibrosis, +5 more
- Locations
-
- University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
- Arizona Liver Health - Chandler Chandler, Arizona, United States
- Arizona Liver Health - Peoria Peoria, Arizona, United States
- Adobe Clinical Research Tucson, Arizona, United States
Active, not recruiting
A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients
NCT06322628
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- Beijing Tsinghua Changgeng Hospital Beijing, Beijing Municipality, China
Active, not recruiting
An Imaging-based Quantitative Biomarker Assay for NAFLD in Children
NCT06354491
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
- Locations
-
- University of Wisconsin, Madison Madison, Wisconsin, United States
Active, not recruiting
LITMUS Imaging Study
NCT05479721
- Conditions
- Digestive System Diseases, Disease, Fatty Liver, +11 more
- Locations
-
- Pinnacle Clinical Research San Antonio, Texas, United States
- Helsinki University Hospital Helsinki, Finland
- Le Centre de Recherche Clinique (CRC) du CHU d'Angers Angers, France
- Institut ICAN - Institute of Cardiometabolism And Nutrition Hôpital de la Pitié Salpêtrière Paris, France
Active, not recruiting
DIAbetes and NAFLD
NCT06315361
- Conditions
- Cirrhosis, Liver, Diabetes, Diabetes Mellitus, +20 more
- Locations
-
- UOSD Diabetologia, Catholic University of Rome, Fondazione Policlinico Gemelli IRCCS Roma, Rome/lazio/italy, Italy